Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-Phospho-CDKN1A (Thr145) Polyclonal Antibody
😃Good
Catalog No. TMAC-02942
Alias p-CDKN1A (Thr145), p-CDKN1A (T145), CDKN1A (p-Thr145), CDKN1A (p-T145)
Anti-Phospho-CDKN1A (Thr145) Polyclonal Antibody is a Rabbit antibody targeting Phospho-CDKN1A (Thr145). Anti-Phospho-CDKN1A (Thr145) Polyclonal Antibody can be used in IHC.
Anti-Phospho-CDKN1A (Thr145) Polyclonal Antibody
Anti-Phospho-CDKN1A (Thr145) Polyclonal Antibody
😃Good
Catalog No. TMAC-02942Alias p-CDKN1A (Thr145), p-CDKN1A (T145), CDKN1A (p-Thr145), CDKN1A (p-T145)
Anti-Phospho-CDKN1A (Thr145) Polyclonal Antibody is a Rabbit antibody targeting Phospho-CDKN1A (Thr145). Anti-Phospho-CDKN1A (Thr145) Polyclonal Antibody can be used in IHC.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 μL | $218 | 7-10 days | 7-10 days | |
| 100 μL | $316 | 7-10 days | 7-10 days |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Anti-Phospho-CDKN1A (Thr145) Polyclonal Antibody is a Rabbit antibody targeting Phospho-CDKN1A (Thr145). Anti-Phospho-CDKN1A (Thr145) Polyclonal Antibody can be used in IHC. |
| Synonyms | p-CDKN1A (Thr145), p-CDKN1A (T145), CDKN1A (p-Thr145), CDKN1A (p-T145) |
| Ig Type | IgG |
| Reactivity | Human |
| Verified Activity | 1. Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using p21Cip1 (Phospho-Thr145) Antibody TMAC-02942 (left) or the same antibody preincubated with blocking peptide (right).  |
| Application | |
| Antibody Type | Polyclonal |
| Host Species | Rabbit |
| Construction | Polyclonal Antibody |
| Purification | Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy using non-phosphopeptide. |
| Appearance | Liquid |
| Formulation | Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
| Research Background | May be the important intermediate by which p53 mediates its role as an inhibitor of cellular proliferation in response to DNA damage. Binds to and inhibits cyclin-dependent kinase activity, preventing phosphorylation of critical cyclin-dependent kinase substrates and blocking cell cycle progression. |
| Conjucates | Unconjugated |
| Others Formats | Phospho |
| Immunogen | Peptide sequence around phosphorylation site of threonine 145 (R-Q-T(p)-S-M) derived from Human p21Cip1 |
| Antigen Species | human |
| Uniprot ID |
Stability & Storage
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Keywords
Preview
Related Tags: buy Anti-Phospho-CDKN1A (Thr145) Polyclonal Antibody | purchase Anti-Phospho-CDKN1A (Thr145) Polyclonal Antibody | Anti-Phospho-CDKN1A (Thr145) Polyclonal Antibody cost | order Anti-Phospho-CDKN1A (Thr145) Polyclonal Antibody
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.